UF Investigators Earn Michael J. Fox Foundation Award

Investigators at UF’s Center for Translational Research in Neurodegenerative Disease, or CTRND, earned a one-year, $200,000 award from the Michael J. Fox Foundation’s Target Advancement Program to explore novel approaches to treat Parkinson’s disease.

“We hope that this study will help us understand more about the role of CB2 in brain immune cells to remove toxic alpha-synuclein and potentially identify specific CB2-targeted therapies for the treatment of Parkinson’s disease,” said Valerie Joers, Ph.D., who will co-lead the study with CTRND Director Malú Tansey, Ph.D.

Learn more about UF Investigators Earn Michael J. Fox Foundation Award.